About Scopio Labs
Scopio Labs is a healthcare AI company that develops full-field digital cell morphology platforms, including the Scopio X100 and X100HT, along with integrated software applications. These platforms are designed to digitize, analyze, and automate the review of blood smears and bone marrow aspirates for clinical laboratories and hospitals. The core of their technology lies in computational photography, which enables the capture of high-resolution (100X) images across the entire field of view of a sample, effectively overcoming the traditional trade-off between resolution and field of view in microscopy.
For physicians and laboratory teams, Scopio Labs’ solutions offer a comprehensive digital picture of blood samples, enhancing diagnostic accuracy and efficiency. The platforms incorporate AI for advanced analysis and decision support, streamlining workflows and facilitating remote consultation and collaboration through secure hospital networks. This capability is particularly beneficial for telehematology, allowing specialists to review and analyze samples from anywhere.
The company’s offerings aim to revolutionize first-line diagnostic testing by expediting access to life-saving treatments and improving patient outcomes through earlier and more accurate detection and diagnosis of various blood-related medical conditions, such as cancers, anemias, and bleeding disorders. Scopio Labs has received FDA clearance and CE marking for its peripheral blood smear and bone marrow aspirate applications, signifying their clinical relevance and readiness for market adoption.
Focus Areas
Business Intelligence
| Key Investors | OurCrowd, Aurum Ventures, Fortissimo Capital, Viola Growth, Ilex Medical, Mizrahi Tefahot Invest, Kreos Capital, B Capital Group, Olive Tree Ventures, Danaher Ventures, Insight Capital Partners |
| Partnerships | Beckman Coulter, Siemens Healthineers |
| Technology | Proprietary Full-Field Digital Cell Morphology platforms, computational photography, AI-powered Decision Support System (DSS), cloud-native for remote review, integration with Laboratory Information Systems (LIS) |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
For physicians, Scopio Labs' technology offers several significant advantages:nn* **Enhanced Diagnostic Confidence:** The Full-Field imaging at 100x magnification provides a complete and detailed view of the entire smear, eliminating the need to revert to a manual microscope and ensuring no diagnostically relevant areas are missed. The AI-powered decision support system offers consistent, standardized analysis, leading to more reliable and accurate diagnoses.n* **Faster Turnaround Times & Efficiency:** Automated workflows and AI analysis significantly reduce the time required for PBS and BMA reviews (e.g., up to 60% reduction in TAT for PBS), allowing for quicker diagnoses and initiation of treatment.n* **Improved Access to Expertise & Collaboration:** Remote review capabilities enable seamless consultation and collaboration with specialists, regardless of their physical location, facilitating second opinions and balancing workloads across different sites.n* **Standardization and Reduced Variability:** The AI-guided system helps standardize cell counting and analysis, reducing inter-operator variability and ensuring consistent quality across the laboratory.n* **Early Detection Potential:** By analyzing significantly more cells than manual methods, the technology improves the statistical significance of findings and the potential for earlier detection of rare cell types and diseases.
Scopio Labs' systems are designed for integration within existing laboratory ecosystems. Their browser-based application can be accessed within a secure medical facility network. They also offer connectivity with other lab automation systems, such as Beckman Coulter's hematology workcells, to create a fully integrated workflow from complete blood count (CBC) to slide staining and peripheral blood smear review.
What the Web Says
Scopio Labs receives generally positive feedback for its innovative digital microscopy technology, particularly its full-field imaging and AI capabilities, which are seen as significant advancements in hematology and pathology. Employer reviews indicate a dynamic, fast-paced work environment with opportunities for growth, though some employees note challenges related to workload and communication in a rapidly expanding company.
Overall: PositiveStrengths
- Innovative full-field imaging and AI for hematology/pathology
- Improved workflow efficiency and diagnostic accuracy
- High-resolution imaging and advanced analytics
- Positive impact on patient care through faster diagnostics
- Dynamic and challenging work environment with growth opportunities
- Strong focus on cutting-edge technology and R&D
Limitations
- Steep learning curve for new users
- Potential for high workload and fast-paced environment
- Some reports of communication challenges in a rapidly growing company
- Integration with existing lab systems can be complex
- Cost of implementation may be a barrier for some labs
- Limited public reviews on specific platforms like Capterra
Based on reviews from: G2, Glassdoor, Healthcare IT News, Reddit, Various industry publications and forums
Last updated: 2026-07-19
Videos
News, demos, and interviews about Scopio Labs.
Videos load interactively. If none appear, search YouTube for Scopio Labs →
Press & Coverage
Investors
Who's funded Scopio Labs.
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]